NCT06881433View on ClinicalTrials.gov

Immune Checkpoint Inhibitors and Anti-vascular Endothelial Growth Factor Antibody/tyrosine Kinase Inhibitors with or Without HAIC for Advanced HCC

RecruitingOBSERVATIONAL

Enrollment

900

Participants

Timeline

Start Date

June 1, 2018

Primary Completion Date

September 30, 2025

Study Completion Date

October 31, 2025

Conditions

Hepatocellular Carcinoma (HCC)

Trial Locations (1)

Unknown

RECRUITING

Zhongda Hospital, Nanjing

All Listed Sponsors

lead

Zhongda Hospital

OTHER